High Times, Low Sats: Diffuse Pulmonary Infiltrates Associated with Chronic Synthetic Cannabinoid Use

Journal of Medical Toxicology

Volumn 9, Issue 2, 2013, Pages 199-206

  Alhadi, Sameir ^a   Tiwari, Anupama ^a   Vohra, Rais ^a   Gerona, Roy ^b   Acharya, Janak ^a   Bilello, Kathryn ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

AM 2201; JWH 018; New drugs of abuse; Pulmonary toxicity; Synthetic cannabinoids

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; AM 2201; AZITHROMYCIN; CANNABINOID; FLUCONAZOLE; JWH 210; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; SYNTHETIC CANNABINOID; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; ADVERSE DRUG REACTION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD ANALYSIS; BODY FLUID; BRONCHUS; CASE REPORT; CONVALESCENCE; DIAGNOSTIC IMAGING; DRUG ABUSE; DRUG MEGADOSE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INHALATION; INTENSIVE CARE; LUNG ALVEOLUS; LUNG INFILTRATE; MALE;

ACCIDENTS, TRAFFIC; ADMINISTRATION, INHALATION; ADULT; CANNABINOIDS; DESIGNER DRUGS; HUMANS; LEUKOCYTOSIS; LUNG; MALE; PNEUMONIA; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; SYNCOPE; TREATMENT OUTCOME; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84878113284     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-013-0288-9     Document Type: Article

References (27)

1. Wells DL, Ott CA (2011) The "new" marijuana. Ann Pharmacother 45(3): 414-417.
2. Vearrier D, Osterhoudt K (2010) A teenager with agitation: higher than she should have climbed. Ped Emerg Care 26(6): 462-465.
3. Seely KA, Lapoint J, Moran JH, Fattore L (2012) Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 2012 Apr 26.
4. Logan BK, Reinhold LE, Xu A, Diamond FX (2012) Identification of synthetic cannabinoids in herbal incense blends in the United States. J Forensic Sci 2012 Jul 26.
5. Tofighi B, Lee JD (2012) Internet highs-seizures after consumption of synthetic cannabinoids purchased online. J Addict Med 6(3): 240-241.
6. Forrester M, Kleinschmidt K, Schwarz E, Young A (2012) Synthetic cannabinoid and marijuana exposures reported to poison centers. Hum Exp Toxicol 2012 Aug 2.
7. Cohen J, Morrison S, Greenberg J, Saidinejad M (2012) Clinical presentation of intoxication due to synthetic cannabinoids. Pediatrics 129(4): e1064-e1067.
8. Ashton JC (2012) Synthetic cannabinoids as drugs of abuse. Curr Drug Abuse Rev 5(2): 158-168.
9. Castellanos D, Thornton G (2012) Synthetic cannabinoid use: recognition and management. J Psychiatr Pract 18(2): 86-93.
10. Rosenbaum CD, Carreiro SP, Babu KM (2012) Here today, gone tomorrow...and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 8(1): 15-32.
11. Vardakou I, Pistos C, Spiliopoulou C (2010) Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett 197(3): 157-162.
12. Atwood BK, Huffman JW, Straiker A et al (2010) JWH018, a common consitiuent of "Spice" herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist. Br J Pharm 160: 585-593.
13. Simmons JR, Skinner CG, Williams J et al (2011) Intoxication from smoking "Spice. Ann Emerg Med 57(2): 187-188.
14. Schneir AB, Cullen J, Ly BT (2011) "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med 40(3): 296-299.
15. Mir A, Obafemi A, Young A, Kane C (2011) Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics 128(6): e1622-e1627.
16. Hurst D, Loeffler G, McLay R (2011) Psychosis associated with synthetic cannabinoid agonists: a case series. Am J Psychiatry 168(10): 1119.
17. Young AC, Schwarz E, Medina G, Obafemi A, Feng SY, Kane C, Kleinschmidt K (2011) Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation. Am J Emerg Med 2011 Jul 28.
18. Fattore L, Fratta W (2011) Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 5(60): 1-12.
19. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA (2007) Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 167: 221-228.
20. Lieberman CM, Lieberman BW (1971) Marihuana-a medical review. N Engl J Med 284: 88-91.
21. Guidotti TL, Laing L, Prakash UB (1989) Clove cigarettes. The basis for concern regarding health effects. West J Med 151(2): 220-228.
22. Bennett GL, Chew FS (1994) Pulmonary carcinoid tumorlets. AJR 162: 568.
23. Loschner A, Cihla A, Jalali F et al (2011) Diffuse alveolar hemorrhage: add "greenhouse effect" to the growing list. Chest 140: 149A.
24. Selman M, Pardo A, King TE (2012) Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med 186(4): 314-324.
25. Sobolevsky T, Prasolov I, Rodchenkov G (2012) Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Test Anal. doi: 10. 1002/dta. 1418.
26. McQuade D, Hudson S, Dargan PI, Wood D (2012) First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. Eur J Clin Pharmacol. doi: 10. 1007/s00228-012-1379-2.
27. EkaJ (20 February 2011). "The night i killed my friends". Erowid. org. Retrieved 2 Dec 2012. http://www. Erowid. org/experiences/exp. php?ID=89294.